Future studies are needed in order to verify the presence of A2B adenosine receptors in primary pancreatic tumors and confirm their pathophysiological functions related to proliferation, metastasis, and chemoresistance in pancreatic cancer. The gene discussed is ADORA2B; the disease is pancreatic neoplasm.